Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marble, M.
Right arrow Articles by Vailed, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marble, M.
Right arrow Articles by Vailed, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

OTHER

Characterization of a cystathionine ß-synthase allele with three mutations in cis in a patient with B6 nonresponsive homocystinuria

Michael Marble1, Michael T. Geraghty1, Raffaella de Franchis2, Jan P. Kraus3 and David Vailed1,2

1Center for Medical Genetics, Department of Pediatrics, Johns Hopkins University School Baltimore, MD 21205 2Howard Hughes Medical Institute, Johns Hopkins University School Baltimore, MD 21205 3Pediatrics and Cellular/Structural Biology, University of Colorado School of Medicine Denver, CO 80262, USA

*To whom correspondence should be addressed

Received July 19, 1994; Accepted July 19, 1994

We used SSCP to survey reverse transcribed-PCR amplified cystathionine synthase cDNAs from patients with homocystinuria. In a single CBS allele, we identified one synonymous and two missense mutations in a portion of the cDNA encoded by a single 135 bp exon which also encodes K119, the putative site of cofactor, pyridoxal 5'-phosphate, binding. The patient, a B6-nonresponsive homocystinuric of Irish descent, is homozygous for a G->A transition at cDNA position 374, a G->C transversion at position 393, and a G->A transition at position 453 resulting in R125Q, E131D and P145P, respectively. Family studies confirmed that all three mutations are present in cis and none were present in 54 Irish and 58 North American controls. R125 is conserved in rat CBS while E131D is conserved in rat CBS, and a related enzyme, O-acetylserine(thiol)-lyase, from a variety of plant and bacterial species. Expression studies showed that both R125Q and E131D, either individually or together, inactivate CBS. The apparently simultaneous appearance of more than one mutation in a single exon suggests they may have arisen by a gene conversion event or by nonhomologous recombination.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Genome ResHome page
S. Cheng, M. A. Grow, C. Pallaud, W. Klitz, H. A. Erlich, S. Visvikis, J. J. Chen, C. R. Pullinger, M. J. Malloy, G. Siest, et al.
A Multilocus Genotyping Assay for Candidate Markers of Cardiovascular Disease Risk
Genome Res., October 1, 1999; 9(10): 936 - 949.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
R. Ameratunga, J. A. Winkelstein, L. Brody, M. Binns, L. C. Cork, P. Colombani, and D. Valle
Molecular Analysis of the Third Component of Canine Complement (C3) and Identification of the Mutation Responsible for Hereditary Canine C3 Deficiency
J. Immunol., March 15, 1998; 160(6): 2824 - 2830.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.